CYTRX Stock Quote

$1.28 arrow  Change: 0.02 %Chge: 1.59% Vol: 1,140
End Of Day Prices
High: 1.28 | Low: 1.26 | Open: 1.26 | Close: 1.28
52 Wk High: 2.45 | 52 Wk Low: 0.32 | Todays Pivot: 1.27
Sector: add stock to watch list

CYTR Chart


You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Online News For Cytrx

5 Biotech Stocks Under $10 Worthy of Investors' Attention

You can see the complete list of today’s Zacks #1 Rank stocks here. CytRx Corporation CYTR is focused on developing oncology treatments. The company’s lead pipeline candidate, aldoxorubicin, is being evaluated in several cancer types including advanced ...


CytRx Corporation Highlights NantCell Inc's Aldoxorubicin Clinical Data Presented at the American Society of Clinical Oncology 2018 Annual Meeting

Data Show Aldoxorubicin, Alone or in Combination with Ifosfamide, Lacks Cardiotoxicity with Doxorubicin Equivalent Doses Beyond 1000 mg/m2 LOS ANGELES, June 7, 2018 /PRNewswire/ -- CytRx Corporation (CYTR), a biopharmaceutical research and development ...


CytRx Corporation Highlights NantCell Inc's Aldoxorubicin Clinic - KAIT Jonesboro, AR - Region 8 News, weather, sports

LOS ANGELES, June 7, 2018 /PRNewswire/ -- CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today highlighted clinical data from partner NantCell's poster presentation on June 2, 2018 at the ...



Want To Add This Quote To Your Site?

With our stock widgets you can add a Cytrx quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for CYTR to choose from. Visit here to build your stock quote widget »